The abstract is read at the publisher; the summary is JClub's.
Patient-derived CASPR2 autoantibodies enhance neuronal network excitability and selectively amplify excitatory synaptic transmission in human and rat primary cortical neurons.
- Why it matters: The pathogenic mechanisms of antibody-mediated neurological disease are unclear, and soluble CASPR2 in CSF may enable an additional autoantibody-driven pathway beyond membrane disruption.
- What they did: The study tested patient polyclonal and monoclonal CASPR2 antibodies in primary cortical neuron cultures, measuring excitability, synaptic transmission, calcium homeostasis, and intrinsic properties, alongside CASPR2 depletion from medium and patient CSF.
- The result: CASPR2 antibodies depleted shed CASPR2 and impaired calcium regulation, while PMCA2 knockdown abrogated antibody effects, identifying shed CASPR2 ectodomain neutralization as linked to PMCA2-mediated calcium control and hyperexcitability.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.